Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 05, 2015 4:48 AM ET

Healthcare Equipment and Supplies

Company Overview of ZELTIQ Aesthetics, Inc.

Company Overview

ZELTIQ Aesthetics, Inc., a medical technology company, engages in developing and commercializing non-invasive products for the selective reduction of fat. It offers CoolSculpting system, which utilizes proprietary controlled cooling technology to selectively reduce stubborn fat bulges. ZELTIQ Aesthetics, Inc. sells its products through a direct sales force, as well as through a network of distributors to dermatologists, plastic surgeons, and aesthetic specialists primarily in North America, the Asia-Pacific, Europe, the Middle East, Africa, and Latin America. The company was formerly known as Juniper Medical, Inc. and changed its name to ZELTIQ Aesthetics, Inc. in July 2007. ZELTIQ Aesthetic...

4698 Willow Road

Pleasanton, CA 94588

United States

Founded in 2005

459 Employees





Key Executives for ZELTIQ Aesthetics, Inc.

Chief Executive Officer, President and Director
Age: 50
Total Annual Compensation: $500.0K
Chief Financial Officer, Principal Accounting Officer and Senior Vice President
Age: 42
Total Annual Compensation: $318.8K
Chief Commercial Officer and Senior Vice President
Age: 57
Total Annual Compensation: $325.0K
Senior Vice President, General Counsel and Corporate Secretary
Age: 53
Total Annual Compensation: $310.0K
Chief Technology Officer
Age: 74
Total Annual Compensation: $300.0K
Compensation as of Fiscal Year 2014.

ZELTIQ Aesthetics, Inc. Key Developments

ZELTIQ Aesthetics, Inc. Announces Resignation of Jean George as Director

On July 27, 2015, Jean George, a director of ZELTIQ Aesthetics, Inc., resigned as a director, effective immediately.

ZELTIQ Aesthetics, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Revises Full Year 2015 Financial Guidance

ZELTIQ Aesthetics, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported revenues of USD 64,431,000 compared to USD 47,061,000 a year ago, total revenue cycles shipped increased 52% to 252,642 for the second quarter 2015, compared to 166,116 for the second quarter 2014. Income from operations was USD 1,653,000 compared to USD 2,765,000 a year ago. Income before income taxes was USD 1,221,000 compared to USD 2,696,000 a year ago. Net income was USD 1,178,000 or USD 0.03 per basic and diluted share compared to USD 2,769,000 or USD 0.07 per basic and diluted share a year ago. Adjusted EBITDA was USD 5,286,000 compared to USD 5,647,000 a year ago. For the six months, the company reported revenues of USD 115,989,000 compared to USD 78,036,000 a year ago. Loss from operations was USD 41,000 compared to USD 4,446,000 a year ago. Loss before income taxes was USD 880,000 compared to USD 4,562,000 a year ago. Net loss was USD 951,000 or USD 0.02 per basic and diluted share compared to USD 4,568,000 or USD 0.12 per basic and diluted share a year ago. Net cash provided by operating activities was USD 7,230,000 compared to net cash used in operating activities of USD 10,331,000 a year ago. Purchase of property and equipment was USD 1,188,000 compared to USD 770,000 a year ago. Adjusted EBITDA was USD 8,254,000 compared to USD 997,000 a year ago. The company revised full year 2015 financial guidance. For the year, the company revenue guidance in the range of USD 245 million to USD 247 million which includes approximately USD 3 million of currency headwinds; up from prior guidance of USD 235 million to USD 238 million. Consumable revenue of approximately 50% of total revenue; unchanged from prior guidance. Gross profit margin of approximately 71% of total revenue; unchanged from prior guidance. Operating expenses in the range of 69% to 70% of total revenue; down from prior guidance of approximately 70%. Stock-based compensation, depreciation, and amortization expense of approximately 7% of total revenue; unchanged from prior guidance. Adjusted EBITDA margin in the range of 8% to 9% of total revenue; up from prior guidance of approximately 8%.

ZELTIQ Aesthetics, Inc. to Report Q2, 2015 Results on Jul 30, 2015

ZELTIQ Aesthetics, Inc. announced that they will report Q2, 2015 results at 1:30 PM, Pacific Standard Time on Jul 30, 2015

Similar Private Companies By Industry

Company Name Region
Nichols Institute Diagnostics, Inc. United States
Dynatek Laboratories, Inc. United States
Sunoptic Technologies LLC United States
B-shoes United States
HealthTronics, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZELTIQ Aesthetics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at